# Esquire Financial Holdings, Inc.: overview

ESQ · Nasdaq · CIK 1531031 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esq.md) · [Financials](/companies/esq/financials.md) · [Filings](/companies/esq/filings.md) · [Insiders](/companies/esq/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.34](/filings/0001104659-25-108508.md) | not reported | [1.33](/filings/0001104659-26-058451.md) | [1.38](/filings/0001104659-26-093295.md) | [1.62](/filings/0001104659-25-108508.md) | not reported | [1.40](/filings/0001104659-26-058451.md) | [1.49](/filings/0001104659-26-093295.md) |
| Free cash flow | $m | [10.5 d](/filings/0001104659-25-108508.md) | [11.6 d](/filings/0001104659-26-027706.md) | [14.7](/filings/0001104659-26-058451.md) | [9.3 d](/filings/0001104659-26-093295.md) | [16.2 d](/filings/0001104659-25-108508.md) | [16.5 d](/filings/0001104659-26-027706.md) | [19.3](/filings/0001104659-26-058451.md) | [14.4 d](/filings/0001104659-26-093295.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.26](/filings/0001558370-24-004363.md) | [3.47](/filings/0001558370-25-003114.md) | [4.91](/filings/0001104659-26-027706.md) | [5.14](/filings/0001104659-26-027706.md) | [5.87](/filings/0001104659-26-027706.md) |
| Free cash flow | $m | [29.1](/filings/0001558370-24-004363.md) | [38.7](/filings/0001558370-25-003114.md) | [41.8](/filings/0001104659-26-027706.md) | [41.5](/filings/0001104659-26-027706.md) | [56.7](/filings/0001104659-26-027706.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/esq/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $71.7m | 601,624 |  | Added +51,278 |
| [Mawer Investment Management Ltd.](/funds/1538449.md) | 2026-06-30 | $69.5m | 583,871 |  | Reduced −141,343 |
| [BASSWOOD CAPITAL MANAGEMENT, L.L.C.](/funds/1085393.md) | 2026-06-30 | $44.0m | 369,416 |  | Added +100,689 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $42.0m | 352,787 |  | Added +86,513 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $37.8m | 317,112 |  | Added +5,289 |
| [Copeland Capital Management, LLC](/funds/1541743.md) | 2026-06-30 | $35.3m | 296,535 |  | Reduced −8,112 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $34.8m | 292,242 |  | Reduced −51,804 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $29.3m | 245,685 |  | Added +15,762 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $28.9m | 242,287 |  | Added +17,485 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $24.4m | 204,697 |  | Added +3,890 |

## Recent filings

[All 593 filings](/companies/esq/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 19:02 ET | [8-K](/filings/0001104659-26-120304.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-120304 |
| 2026-10-27 | 08:30 ET | [8-K](/filings/0001104659-26-118993.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118993 |
| 2026-10-15 | 07:00 ET | [8-K/A](/filings/0001104659-26-115958.md) | 9.01 Financial statements and exhibits | 0001104659-26-115958 |
| 2026-08-10 | 14:54 ET | [10-Q](/filings/0001104659-26-093295.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093295 |
| 2026-08-03 | 08:55 ET | [8-K](/filings/0001104659-26-089537.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089537 |
| 2026-07-30 | 16:30 ET | [8-K](/filings/0001104659-26-088725.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088725 |
| 2026-07-23 | 08:30 ET | [8-K](/filings/0001104659-26-086092.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-086092 |
| 2026-06-24 | 09:00 ET | [8-K](/filings/0001104659-26-077082.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-077082 |
| 2026-06-09 | 16:06 ET | [8-K](/filings/0001104659-26-071835.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071835 |
| 2026-05-28 | 16:05 ET | [8-K](/filings/0000943374-26-000216.md) | 5.07 Shareholder vote results | 0000943374-26-000216 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-027706.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1531031
- Tickers: ESQ
- Exchange: Nasdaq
- SIC code: 6029 Commercial Banks, NEC
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:23 ET. No prices; not investment advice.